An Open-Label Trial of Dexlansoprazole 60mg for the Relief of Heartburn During the Fasting Month of Ramadan
Sponsor: American University of Beirut Medical Center
This PHASE4 trial investigates GERD and Proton Pump Inhibitor and is currently completed. American University of Beirut Medical Center leads this study, which shows 7 recorded versions since 2017 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE4
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE4
-
Oct 2017 — Jun 2018 [monthly]
Completed PHASE4
Status: Recruiting → Completed
▶ Show 2 earlier versions
-
Jun 2017 — Oct 2017 [monthly]
Recruiting PHASE4
Phase: PHASE3 → PHASE4
-
May 2017 — Jun 2017 [monthly]
Recruiting PHASE3
First recorded
Feb 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- American University of Beirut Medical Center
- Takeda
For direct contact, visit the study record on ClinicalTrials.gov .